Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1955 Feb 26;1(4912):495–501. doi: 10.1136/bmj.1.4912.495

Factors Influencing Adrenocortical Activity in Health and Disease*

R L S Bayliss
PMCID: PMC2061165  PMID: 13230533

Full text

PDF
500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTTER F. C., ALBRIGHT F., FORBES A. P., LEAF A., DEMPSEY E., CARROLL E. The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern. J Clin Invest. 1951 Mar;30(3):237–251. doi: 10.1172/JCI102438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BAYLISS R. I., DEMPSTER W. J., ROUND B. P., STEINBECK A. W. Route of absorption of oral cortisone in the dog. Clin Sci. 1954 Aug;13(3):377–382. [PubMed] [Google Scholar]
  3. BONGIOVANNI A. M., EBERLEIN W. R., CARA J. Studies on the metabolism of adrenal steroids in the adrenogenital syndrome. J Clin Endocrinol Metab. 1954 Apr;14(4):409–422. doi: 10.1210/jcem-14-4-409. [DOI] [PubMed] [Google Scholar]
  4. BORST J. G. G. De uitscheiding van water on electrolyten gedurende het etmaal en onder invloed van succus liquiritiae. Ned Tijdschr Geneeskd. 1950 Dec 9;94(49):3608–3611. [PubMed] [Google Scholar]
  5. BORST J. G. G., TEN HOLT S. P., DE VRIES L. A., MOLHUYSEN J. A. Synergistic action of liquorice and cortisone in Addison's and Simmonds's disease. Lancet. 1953 Apr 4;1(6762):657–663. doi: 10.1016/s0140-6736(53)91800-5. [DOI] [PubMed] [Google Scholar]
  6. CARD W. I., MITCHELL W., STRONG J. A., TAYLOR N. R. W., TOMPSETT S. L., WILSON J. M. G. Effects of liquorice and its derivatives on salt and water metabolism. Lancet. 1953 Apr 4;1(6762):663–668. doi: 10.1016/s0140-6736(53)91801-7. [DOI] [PubMed] [Google Scholar]
  7. COPE C. L., BOYSEN X., McCRAE S. Some observations on endogenous cortisone excretion in man. Br Med J. 1951 Sep 29;2(4734):762–767. doi: 10.1136/bmj.2.4734.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. COPE C. L., HURLOCK B. The 17-hydroxycorticosterone content of human ascitic fluid. Br Med J. 1953 Oct 3;2(4839):753–755. doi: 10.1136/bmj.2.4839.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DONE A. K., ELY R. S., KELLEY V. C. Studies on 17-hydroxycorticosteroids. III. Blood levels in salicylate intoxication. J Pediatr. 1954 Feb;44(2):153–158. doi: 10.1016/s0022-3476(54)80234-4. [DOI] [PubMed] [Google Scholar]
  10. FRANKSSON C., GEMZELL C. A., VON EULER U. S. Cortical and medullary adrenal activity in surgical and allied conditions. J Clin Endocrinol Metab. 1954 Jun;14(6):608–621. doi: 10.1210/jcem-14-6-608. [DOI] [PubMed] [Google Scholar]
  11. GARDNER L. I., MIGEON C. J. Urinary dehydroisoandrosterone in hyperadrenocorticism: influence of cortisone, hydrocortisone and ACTH. J Clin Endocrinol Metab. 1952 May;12(9):1117–1139. doi: 10.1210/jcem-12-9-1117. [DOI] [PubMed] [Google Scholar]
  12. GEMZELL C. A. Blood levels of 17-hydroxycorticosteroids in normal pregnancy. J Clin Endocrinol Metab. 1953 Aug;13(8):898–902. doi: 10.1210/jcem-13-8-898. [DOI] [PubMed] [Google Scholar]
  13. GEMZELL C. A., FRANKSSON C. The effect of ACTH on the blood level of 17-hydroxycorticosteroids and the circulating eosinophils in man. Acta Endocrinol (Copenh) 1953 Nov;14(3):205–213. doi: 10.1530/acta.0.0140205. [DOI] [PubMed] [Google Scholar]
  14. GREENE R., VAUGHN-MORGAN J. Corticotrophin zinc phosphate; a long-acting aqueous preparation. Lancet. 1954 Mar 13;266(6811):543–545. doi: 10.1016/s0140-6736(54)91309-4. [DOI] [PubMed] [Google Scholar]
  15. GREENSPAN F. S., LI C. H., EVANS H. M. Disappearance rate of adrenocorticotropic hormone from rat's plasma after intravenous injection. Endocrinology. 1950 Mar;46(3):261–264. doi: 10.1210/endo-46-3-261. [DOI] [PubMed] [Google Scholar]
  16. GROEN J., PELSER H., WILLEBRANDS A. F., KAMMINGA C. E. Extract of licorice for the treatment of Addison's disease. N Engl J Med. 1951 Mar 29;244(13):471–475. doi: 10.1056/NEJM195103292441303. [DOI] [PubMed] [Google Scholar]
  17. JAILER J. W., KNOWLTON A. I. Simulated adreno-cortical activity during pregnancy in an Addisonian patient. J Clin Invest. 1950 Nov;29(11):1430–1436. doi: 10.1172/JCI102381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. JAILER J. W., LOUCHART J., CAHILL G. F. Adrenal virilism. I. Diagnostic considerations and treatment. J Am Med Assoc. 1952 Oct 11;150(6):575–579. doi: 10.1001/jama.1952.03680060047013. [DOI] [PubMed] [Google Scholar]
  19. KARK R. M., MUEHRCKE R. C. Does adrenaline eosinopenia reflect pituitary-adrenal function in man? Lancet. 1952 Jun 14;1(6720):1189–1191. doi: 10.1016/s0140-6736(52)91089-1. [DOI] [PubMed] [Google Scholar]
  20. LOUCHART J., JAILER J. W. Inactivation of 11-dehydro-17-hydroxycorticosterone by tissue slices. Proc Soc Exp Biol Med. 1952 Mar;79(3):393–396. doi: 10.3181/00379727-79-19391. [DOI] [PubMed] [Google Scholar]
  21. NELSON D. H., SAMUELS L. T., WILLARDSON, TYLER F. H. The levels of 17-hydroxycorticosteroids in peripheral blood of human subjects. J Clin Endocrinol Metab. 1951 Sep;11(9):1021–1029. doi: 10.1210/jcem-11-9-1021. [DOI] [PubMed] [Google Scholar]
  22. OPSAHL J. C., LONG C. N. H. Identification of ACTH in human placental tissue. Yale J Biol Med. 1951 Dec;24(3):199–209. [PMC free article] [PubMed] [Google Scholar]
  23. PORTER C. C., SILBER R. H. A quantitative color reaction for cortisone and related 17,21-dihydroxy-20-ketosteroids. J Biol Chem. 1950 Jul;185(1):201–207. [PubMed] [Google Scholar]
  24. PRUNTY F. T., McSWINEY R. R., MILLS I. H., SMITH M. A. The effects of aldosterone in Addison's disease and adrenal pseudohermaphroditism. Lancet. 1954 Sep 25;267(6839):620–624. doi: 10.1016/s0140-6736(54)90402-x. [DOI] [PubMed] [Google Scholar]
  25. REDDY W. J., JENKINS D., THORN G. W. Estimation of 17-hydroxycorticoids in urine. Metabolism. 1952 Nov;1(6):511–527. [PubMed] [Google Scholar]
  26. REISS M., BADRICK F. E., HALKERSTON I. D. K., PLAICE C. Inactivation of adrenotropic hormone (ACTH) by plasma. Nature. 1951 Aug 4;168(4266):206–206. doi: 10.1038/168206a0. [DOI] [PubMed] [Google Scholar]
  27. RENOLD A. E., JENKINS D., FORSHAM P. H., THORN G. W. The use of intravenous ACTH: a study in quantitative adrenocortical stimulation. J Clin Endocrinol Metab. 1952 Jul;12(7):763–797. doi: 10.1210/jcem-12-7-763. [DOI] [PubMed] [Google Scholar]
  28. SANDBERG A. A., NELSON D. H., PALMER J. G., SAMUELS L. T., TYLER F. H. The effects of epinephrine on the metabolism of 17-hydroxycorticosteroids in the human. J Clin Endocrinol Metab. 1953 Jun;13(6):629–647. doi: 10.1210/jcem-13-6-629. [DOI] [PubMed] [Google Scholar]
  29. SAYERS G. The adrenal cortex and homoestasis. Physiol Rev. 1950 Jul;30(3):241–320. doi: 10.1152/physrev.1950.30.3.241. [DOI] [PubMed] [Google Scholar]
  30. SIMPSON S. A., TAIT J. F., WETTSTEIN A., NEHER R., VON EUW J., SCHINDLER O., REICHSTEIN T. Konstitution des Aldosterons, des neuen Mineralocorticoids. Experientia. 1954 Mar 15;10(3):132–133. doi: 10.1007/BF02158515. [DOI] [PubMed] [Google Scholar]
  31. TARANTINO C. Sulla presenza di ACTH nella placenta. Folia Endocrinol Mens Incretologia Incretoterapia. 1951 Apr;4(2):197–201. [PubMed] [Google Scholar]
  32. VAN CAUWENBERGE H., BETZ H. Salicylates and neuro-endocrine stimulation. Lancet. 1952 May 31;1(6718):1083–1086. doi: 10.1016/s0140-6736(52)90743-5. [DOI] [PubMed] [Google Scholar]
  33. VAN CAUWENBERGE H., HEUSGHEM C. Acetylsalicylic acid and urinary excretion of adrenocortical steroids. Lancet. 1951 Apr 7;1(6658):771–773. doi: 10.1016/s0140-6736(51)92189-7. [DOI] [PubMed] [Google Scholar]
  34. VENNING E. H., RANDALL J. P., GYORGY P. Excretion of glucocorticoids in the newborn. Endocrinology. 1949 Oct;45(4):430–434. doi: 10.1210/endo-45-4-430. [DOI] [PubMed] [Google Scholar]
  35. WILKINS L., GARDNER L. I., CRIGLER J. F., Jr, SILVERMAN S. H., MIGEON C. J. Further studies on the treatment of congenital adrenal hyperplasia with cortisone. I. Comparison of oral and intramuscular administration of cortisone, with a note on the suppressive action of compounds F and B on the adrenal. J Clin Endocrinol Metab. 1952 Mar;12(3):257–276. doi: 10.1210/jcem-12-3-257. [DOI] [PubMed] [Google Scholar]
  36. WILKINS L., LEWIS R. A., KLEIN R., GARDNER L. I., CRIGLER J. F., Jr, ROSEMBERG E., MIGEON C. J. Treatment of congenital adrenal hyperplasia with cortisone. J Clin Endocrinol Metab. 1951 Jan;11(1):1–25. doi: 10.1210/jcem-11-1-1. [DOI] [PubMed] [Google Scholar]
  37. WILSON H., GLYN J., SCULL E., McEWEN C., ZIFF M. Rate of disappearance and metabolism of hydrocortisone and cortisone in the synovial cavity in rheumatoid arthritis. Proc Soc Exp Biol Med. 1953 Jul;83(3):648–654. doi: 10.3181/00379727-83-20447. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES